Emmanuel Ekpor
Prevalence of dyslipidemia among persons with type 2 diabetes in africa: a systematic review and meta-analysis
Journal title : Annals of Medicine & Surgery
Publisher : Ovid Technologies (Wolters Kluwer Health)
Online ISSN : 2049-0801
139 Views Reviews Article
Background: Dyslipidemia is an established cardiovascular risk factor in persons with type 2 diabetes (T2D), yet the extent to which these conditions co-occur in Africa is unknown. This systematic review and meta-analysis aimed to determine the prevalence of dyslipidemia among persons with T2D in Africa. Methods: Medline, Embase, Global Health, Scopus, and Web of Science were searched on 5 December 2023. This review adhered to the PRISMA guidelines and was prospectively registered on PROSPERO. The prevalence data for dyslipidemia was pooled through a random-effects meta-analysis. The authors assessed heterogeneity and publication bias using I2 statistics and Egger’s test, respectively. Results: Our search identified 8035 records, of which 60 articles involving 20 034 individuals with T2D were included in this review. The pooled prevalence of dyslipidemia recorded 38.6% (95% CI: 34.1–43.4) for high TC (≥ 5.2 mmol/l), 52.7% (95% CI: 44.2–61.1) for high low-density lipoprotein cholesterol (LDL-C) (≥ 2.6 mmol/l), 43.5% (95% CI: 37.1–50.0) for low high-density lipoprotein cholesterol (HDL-C) (< 1.0 mmol/l in men and less than 1.3 mmol/l in women), and 37.4% (95% CI: 32.2–42.9) for high triglycerides (TG) (≥ 1.7 mmol/l). Subgroup analysis based on gender indicated a notably higher prevalence of dyslipidemia among females compared to males. Conclusion: Dyslipidemia is prevalent among persons with T2D in Africa. This highlights the need for early screening, diagnosis, and management of dyslipidemia to mitigate the risk of cardiovascular complications in this population.
Article DOI & Crossmark Data
DOI : https://doi.org/10.1097/MS9.0000000000002122
Article Subject Details
Article Keywords Details
Article File
Full Text PDFArticle References
- (1). 10.2337/dc21-0365
- (2). 10.4103/2230-8210.183480
- (3). 10.1016/j.metabol.2014.08.010
- (4). 10.2147/IJGM.S377463
- (5). 10.1186/s13104-017-2465-4
- (6). 10.1161/JAHA.120.016947
- (7). 10.1186/1471-2458-7-186
- (8). 10.2337/dc23-S010
- (9). 10.3389/fpubh.2020.532719
- (10). 10.1080/07853890.2023.2182909
- (11). 10.1186/s13104-019-4423-9
- (12). 10.3389/fphar.2020.00108
- (13). 10.1371/journal.pmed.1000097
- (14). 10.1161/circ.106.25.3143
- (15). 10.1097/XEB.0000000000000054
- (16). 10.1890/10-0340.1
- (17). 10.1002/sim.1186
- (18). 10.1136/bmj.315.7109.629
- (19). 10.1016/j.diabres.2011.10.018
- (20). 10.4103/0300-1652.126296
- (21). 10.1186/1758-5996-2-24
- (22). 10.4103/1119-3077.94089
- (23). 10.4103/1596-3519.87045
- (24). 10.1186/s12872-020-01395-3
- (25). 10.11604/pamj.2019.34.123.18717
- (26). 10.11604/pamj.2022.43.148.36586
- (27). 10.1016/S1665-2681(19)31559-5
- (28). 10.1155/2018/1838162
- (29). 10.1007/s12291-010-0101-3
- (30). 10.3390/medicina55070392
- (31). 10.1080/2331205X.2019.1639880
- (32). 10.4103/2229-516X.157170
- (33). 10.1155/2018/4783093
- (34). 10.1016/j.heliyon.2022.e10279
- (35). 10.1186/s12872-022-02805-4
- (36). 10.1007/s10389-020-01205-2
- (37). 10.1186/s12944-018-0926-y
- (38). 10.2147/DMSO.S283171
- (39). 10.1371/journal.pone.0262610
- (40). 10.1080/16089677.2018.1541668
- (41). 10.2147/DMSO.S368165
- (42). 10.1186/s12872-018-0880-7
- (43). 10.1186/s13104-019-4609-1
- (44). 10.1186/s12902-017-0226-y
- (45). 10.1371/journal.pone.0241432
- (46). 10.3389/fcdhc.2023.1234674
- (47). 10.2147/DMSO.S221429
- (48). 10.1080/20786190.2018.1527134
- (49). 10.1186/s12902-021-00813-7
- (50). 10.3390/ijerph17238735
- (51). 10.7196/SAMJ.2016.v106i9.9899
- (52). 10.1089/met.2008.0003
- (53). 10.1186/s12902-017-0223-1
- (54). 10.1186/s12882-020-1705-3
- (55). 10.18697/ajfand.87.18420
- (56). 10.1016/j.dsx.2017.07.039
- (57). 10.1016/j.ajg.2015.06.001
- (58). 10.1186/s12902-022-01060-0
- (59). 10.1155/2020/5901569
- (60). 10.1007/s00592-009-0093-8
- (61). 10.1016/j.dsx.2019.02.008
- (62). 10.21608/asejaiqjsae.2020.91324
- (63). 10.11604/pamj.2022.43.86.35898
- (64). 10.1186/s40001-022-00882-x
- (65). 10.4314/ahs.v23i1.54
- (66). 10.1016/S2214-109X(18)30275-4
- (67). 10.1038/s41598-023-38275-7
- (68). 10.1371/journal.pgph.0001931
- (69). 10.1016/j.gfs.2020.100466
- (70). 10.1371/journal.pone.0187347
- (71). 10.1371/journal.pone.0111812
More Article by Emmanuel Ekpor
Background type 2 diabetes and obesity are serious public health concerns globally and a growing burden in africa. both conditions have serious repercussions on health when they co...
Background type 2 diabetes and obesity are serious public health concerns globally and a growing burden in africa. both conditions have serious repercussions on health when they co...
Online interviews can be powerful tools in global health research. in this article, we review the literature on the use of and challenges associated with online interviews in healt...
The utilization of traditional medicine (tm) is prevalent among the general population in africa; however, its use among individuals with diabetes in the region remains underdocume...
More Biochemistry clinical laboratory Articles
Metapuf: a challenge response pair generator
Views: 1.5K